In his weekly clinical update Dr. Griffin reviews the public health response to poliovirus in New York, impact of mandatory influenza vaccination, monkeypox in a young infant, health care worker exposure to monkeypox virus, monkeypox testing delays, transmission potential of monkeypox virus, TPOXX trial for monkeypox, detection of SARS-CoV-2 subgenomic mRNA, mucosal IgA against SARS-CoV-2, BNT262b2 against Omicron, awareness and use of SARS-CoV-2 antivirals, comparable outcomes for Bebtelovimab and Nirmatrelvir, and COVID-19 and Alzheimer’s disease.
Click arrow to play
Download TWiV 938 (32 MB .mp3, 53 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Show notes at microbe.tv/twiv
1 thought on “TWiV 938: Clinical update with Dr. Daniel Griffin”
Background information; I am 64yrs white female living in Birmingham, Alabama, and have CVID treated with subcutaneous immune globulin and autoimmune D/O’s. -After each vaccine, I have had strange reactions such as Inflammation of internal organs, yet different each time. With each vaccine, the physical reactions have gotten unceasingly severe. The last shot I had was last Feb. 2022; Within 24 hours I first collapsed unconscious and wound up in Intensive Care for a week, disoriented for the first 2 days after the initial collapse into unconsciousness. The doctors did every test they could think of without finding a cause for this ‘problem’. I am now very afraid of continuing to get boosters and I need to know what you think.
Comments are closed.